News
12-14-2008, 08:00 PM
Femara showed reduced risk of death by 13% (P=0.08) versus tamoxifen, despite inclusion of patients who had switched over from tamoxifen to Femara during the study period, following the study's unblinding
More... (http://www.news-medical.net/?id=44170)
More... (http://www.news-medical.net/?id=44170)